• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDACTA INTERNATIONAL SA TRANSFORAMINAL INTERBODY FUSION DEVICE 12X30X8 L5°

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDACTA INTERNATIONAL SA TRANSFORAMINAL INTERBODY FUSION DEVICE 12X30X8 L5° Back to Search Results
Catalog Number 03.23.051
Health Effect - Clinical Code Failure of Implant (1924)
Date of Event 05/31/2018
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Batch review performed on (b)(6) 2018, lot 144046: (b)(4) items manufactured and released on (b)(6) 2014.Expiration date: 08/31/2019.No anomalies found related to the problem.To date, (b)(4) items of the same lot have been already sold without any similar reported event.Clinical evaluation performed on (b)(6) 2018 by medical affairs director expulsion of a tlif cage at l4-l5 one month after operation.This cage was used to replace a former (larger) similar cage that incurred into the same adverse event.It was substituted by an alif cage.There is no clue that the problem was originated by a faulty or malfunctioning device.Cage expulsion is a known, possible adverse event following interbody fusion surgery, described in literature.Preliminary investigation performed by r&d spine director on (b)(6) 2018: implant migration can occur among others because of a too small implant size selection.
 
Event or Problem Description
The patient had a primary on (b)(6) 2018.On (b)(6) 2018 the surgeon revised the patient cage because slipped and was pressing on the thecal sack, with a smaller cage (mdr 2018-00381).Also the 2nd cage slipped and was pressing on the thecal sack,it migrated toward the thecal sack 1 month later.
 
Additional Manufacturer Narrative
Due to human error the follow up was reported not on time.Visual inspection performed by r&d project manager on 21 june 2018: the mectalif transforaminal 03.23.051, lot 144046, analyzed is according to the specification in terms of external dimensions.The part presents some scratches that are probably due to the removal of the implant.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TRANSFORAMINAL INTERBODY FUSION DEVICE 12X30X8 L5°
Common Device Name
TRANSFORAMINAL INTERBODY FUSION DEVICE
Manufacturer (Section D)
MEDACTA INTERNATIONAL SA
strada regina
castel san pietro, switzerland 6874
SZ  6874
MDR Report Key7605420
Report Number3005180920-2018-00434
Device Sequence Number1695677
Product Code MAX
UDI-Device Identifier07630030828966
UDI-Public07630030828966
Combination Product (Y/N)N
Initial Reporter StateIL
Initial Reporter CountryUS
PMA/510(K) Number
K131671
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2018
Device Explanted Year2018
Reporter Type Manufacturer
Report Source company representative
Initial Reporter Occupation Other
Type of Report Initial,Followup
Report Date (Section B) 08/29/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date08/31/2019
Device Catalogue Number03.23.051
Device Lot Number144046
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer06/21/2018
Was the Report Sent to FDA? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 05/17/2018
Supplement Date Received by Manufacturer05/17/2018
Initial Report FDA Received Date06/15/2018
Supplement Report FDA Received Date08/29/2018
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age54 YR
-
-